The prognosis of pancreatic cancer is extremely poor and early diagnosis is difficult. At the time of diagnosis, local vascular involvement, nodal and distant metastases are frequently present.
No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2004 ASCO Annual Meeting. This abstract does not include a full text component.
Demographic factors on the incidence of KRAS mutation in colorectal cancers. Background: Serum tumour markers have an established role in the monitoring of systemic treatment for trophoblastic, ...
“[...] these inexpensive, widely available tests with rapid turnaround times and relatively short half-lives (CEA, CA-125, and CA19-9) are perfectly situated to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results